Fundamentals of Biotech Valuations

10,000 SEK + VAT

The Fundamentals course is an introduction of different valuation approaches, which is then followed by a deep dive of the essential assumptions for biotech valuation. Supporting examples of benchmark data and references that stands behind those key assumptions will be included. Furthermore, there will be practical examples to demonstrate how to perform more hands-on valuation modelling and to stress test your model through scenario planning.

Agenda:

  • Introduction to valuation
  • Valuation methods
  • Intro to NPV and rNPV
  • Value creation in drug development
  • Analyzing and quantifying your addressable market
  • Revenue forecasting and scenario planning
  • R&D timeline and cost analysis
  • Estimating and benchmarking post-approval costs
  • Adjusting for development and market risk
  • Valuation in practice

8 in stock

SKU: 1-1 Category:

Each course is scheduled in one day over five hours in two sessions (one session before lunch + one session after lunch). The course will be held in central Stockholm. To maximize interactivity, we run a small group.

In addition to the course presentations and workshops, we will provide one physical copy of Biotech Valuation – A playbook for deal makers per attendee. Furthermore, we will provide spreadsheet valuation models where you can insert various parameters to model revenue forecasts as well as calculating a risk-adjusted net present values.